First, all samples were collected during radical cystectomy; thus, we lacked data on MCT4 protein expression in early-stage bladder cancer and metastatic bladder cancer, which are not eligible for radical cystectomy. This evidence concerns the gene SLC16A3 and urinary bladder carcinoma.